-
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialRidker PM, MacFadyen JG, CANTOS Trial Group et al. -
Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer PatientsYJ Youn, J-W Lee, J Yoon et al.
-
Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection FractionGivertz MM, Stevenson LW, CHAMPION Trial Investigators et al.
-
Basic Biology of Oxidative Stress and the Cardiovascular System: Part 1 of a 3-Part SeriesSack MN, Fyhrquist FY, Kovacic JC et al.
-
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year OutcomesShah KS, Xu H, Fonarow GC et al.
-
Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking ProgramValle JA,, Glorioso TJ, Bricker R et al.
-
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?Wehner GJ, Jing L, Haggerty CM et al.
-
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and BeyondLibby P
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
